Skip to main content
Signal8

Wong Hing C

SEC insider (Form 3/4/5 filer). CIK 0001866258. Chief Executive Officer at HCW Biologics Inc. (HCWB). 4 reported Form 4/5 transactions since Sep 2024; latest on May 22, 2026. Located in MIRAMAR,, FL.

Companies Wong Hing C has filed insider reports for

  • HCW Biologics Inc. (HCWB): Director, Officer, 10% Owner, Chief Executive Officer
Wong Hing C profile photo

Wong Hing C

CIK: 0001866258

Transaction Breakdown

Open Market Buys (P)4 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

HCW Biologics Inc. logo
HCWB

HCW Biologics Inc.

DirectorOfficer10% Owner

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • HCW Biologics Inc. logo
    HCWB

    HCW Biologics Inc.

    May 22, 2026
    Purchase
    Direct
    113.9K shares at avg. $1.41$160K
  • HCW Biologics Inc. logo
    HCWB

    HCW Biologics Inc.

    May 16, 2025
    Purchase
    Direct
    8.1K shares at avg. $7.45$60K
  • HCW Biologics Inc. logo
    HCWB

    HCW Biologics Inc.

    May 8, 2025
    Purchase
    Direct
    92.5K shares at avg. $26.00$2.4M
  • HCW Biologics Inc. logo
    HCWB

    HCW Biologics Inc.

    May 7, 2025
    Purchase

    Common Stock Purchase Warrant

    Direct
    46.3K shares-

1-4 of 4